249 related articles for article (PubMed ID: 16228279)
1. Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs.
Arther RG; Bowman DD; Slone RL; Travis LE
Parasitol Res; 2005 Oct; 97 Suppl 1():S76-S80. PubMed ID: 16228279
[TBL] [Abstract][Full Text] [Related]
2. Safety of imidacloprid plus moxidectin topical solution applied to cats heavily infected with adult heartworms (Dirofilaria immitis).
Arther RG; Atkins C; Ciszewski DK; Davis WL; Ensley SM; Settje TL
Parasitol Res; 2005 Oct; 97 Suppl 1():S70-S75. PubMed ID: 16228278
[TBL] [Abstract][Full Text] [Related]
3. Assessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline.
Savadelis MD; Ohmes CM; Hostetler JA; Settje TL; Zolynas R; Dzimianski MT; Moorhead AR
Parasit Vectors; 2017 May; 10(1):245. PubMed ID: 28526088
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of 10% imidacloprid + 2.5% moxidectin topical solution (Advantage Multi
Bowman DD; Ohmes CM; Hostetler JA; Keil DJ; Settje TL; Charles SD
Parasit Vectors; 2017 Nov; 10(Suppl 2):478. PubMed ID: 29143660
[TBL] [Abstract][Full Text] [Related]
5. Laboratory Evaluation of the Efficacy of 10 % Imidacloprid + 2.5 % Moxidectin Topical Solution (Advantage® Multi, Advocate®) for the Treatment of Dirofilaria immitis Circulating Microfilariae in Dogs.
Bowman DD; Charles SD; Arther RG; Settje T
Parasitol Res; 2015 Aug; 114 Suppl 1():S165-74. PubMed ID: 26152417
[TBL] [Abstract][Full Text] [Related]
6. Protection of dogs against canine heartworm infection 28 days after four monthly treatments with Advantage Multi® for Dogs.
Bowman DD; Grazette AR; Basel C; Wang Y; Hostetler JA
Parasit Vectors; 2016 Jan; 9():12. PubMed ID: 26746229
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of 10% imidacloprid+2.5% moxidectin for the treatment of Dirofilaria immitis circulating microfilariae in experimentally infected dogs.
McCall JW; Arther R; Davis W; Settje T
Vet Parasitol; 2014 Nov; 206(1-2):86-92. PubMed ID: 25444277
[TBL] [Abstract][Full Text] [Related]
8. Experimental Dirofilaria immitis infection in dogs: effects of doxycycline and Advantage Multi® administration on immature adult parasites.
Chandrashekar R; Beall MJ; Saucier J; O'Connor T; McCall JW; McCall SD
Vet Parasitol; 2014 Nov; 206(1-2):93-8. PubMed ID: 25218886
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs.
Petry G; Genchi M; Schmidt H; Schaper R; Lawrenz B; Genchi C
Parasitol Res; 2015 Aug; 114 Suppl 1():S131-44. PubMed ID: 26152414
[TBL] [Abstract][Full Text] [Related]
10. Chemoprophylaxis of Dirofilaria immitis (Leidy 1856) infection at a high challenge environment.
Labarthe NV; Willi LM; Paiva JP; Miranda MG; Zoreck K; Almeida FM
Parasit Vectors; 2015 Oct; 8():523. PubMed ID: 26459036
[TBL] [Abstract][Full Text] [Related]
11. Heartworm control in Grenada, West Indies: Results of a field study using imidacloprid 10% + moxidectin 2.5% and doxycycline for naturally-acquired Dirofilaria immitis infections.
Paterson T; Fernandez C; Burnett PJ; Lessey L; Hockley T; Hagen R; Coomansingh C; Sharma B; Chandrashekar R; Schaper R
Vet Parasitol; 2020 Aug; 284():109194. PubMed ID: 32866837
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis.
Blagburn BL; Arther RG; Dillon AR; Butler JM; Bowles JV; von Simson C; Zolynas R
Parasit Vectors; 2016 Apr; 9():191. PubMed ID: 27044379
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of imidacloprid 10%/moxidectin 2.5% spot on (Advocate®, Advantage Multi®) and doxycycline for the treatment of natural Dirofilaria immitis infections in dogs.
Genchi M; Vismarra A; Lucchetti C; Viglietti A; Crosara S; Gnudi G; Quintavalla C; Schaper R; Kramer L
Vet Parasitol; 2019 Sep; 273():11-16. PubMed ID: 31442887
[TBL] [Abstract][Full Text] [Related]
14. Imidacloprid/moxidectin topical solution for the prevention of heartworm disease and the treatment and control of flea and intestinal nematodes of cats.
Arther RG; Charles S; Ciszewski DK; Davis WL; Settje TS
Vet Parasitol; 2005 Oct; 133(2-3):219-25. PubMed ID: 16198823
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
Krieger K; Heine J; Dumont P; Hellmann K
Parasitol Res; 2005 Oct; 97 Suppl 1():S81-S88. PubMed ID: 16228280
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of the safety and efficacy of 10% imidacloprid + 2.5% moxidectin topical solution for the treatment of ear mite (Otodectes cynotis) infestations in dogs.
Arther RG; Davis WL; Jacobsen JA; Lewis VA; Settje TL
Vet Parasitol; 2015 May; 210(1-2):64-8. PubMed ID: 25801226
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of heat-treating heartworm-positive canine serum samples during treatment with Advantage Multi
Savadelis MD; Roveto JL; Ohmes CM; Hostetler JA; Settje TL; Dzimianski MT; Moorhead AR
Parasit Vectors; 2018 Feb; 11(1):98. PubMed ID: 29458396
[TBL] [Abstract][Full Text] [Related]
18. Field efficacy and safety of a combination of moxidectin and imidacloprid for the prevention of feline heartworm (Dirofilaria immitis) infection.
Venco L; Mortarino M; Carro C; Genchi M; Pampurini F; Genchi C
Vet Parasitol; 2008 Jun; 154(1-2):67-70. PubMed ID: 18395348
[TBL] [Abstract][Full Text] [Related]
19. Microfilaricidal efficacy of a single administration of Advocate(®) (Bayer Animal Health) in dogs naturally infected with Dirofilaria immitis or Dirofilaria repens.
Frangipane di Regalbono A; Di Cesare A; Traversa D; Simonato G; Poser H; Danesi P; Furnari C; Russi I; Raele DA; Crisi P; Pampurini F; Pietrobelli M
Vet Parasitol; 2016 Aug; 226():30-4. PubMed ID: 27514879
[TBL] [Abstract][Full Text] [Related]
20. Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs.
Kryda K; Six RH; Walsh KF; Holzmer SJ; Chapin S; Mahabir SP; Myers M; Inskeep T; Rugg J; Cundiff B; Pullins A; Ulrich M; McCall JW; McTier TL; Maeder SJ
Parasit Vectors; 2019 Sep; 12(1):445. PubMed ID: 31506094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
